Skip to main content

Brook.ai

Category: AI in Healthcare

AI-powered remote care platform that combines intelligent data collection and analysis with compassionate support from skilled health specialists to manage chronic conditions Brook.ai was founded in 2015. The company is led by Oren Nissim. Based in Bellevue, Washington, USA. Team size: 51-200. Total funding raised: $40M. Latest round: Series B, $28M, October 2025, led by UMass Memorial Health and Morningside (co-leads). Key investors include UMass Memorial Health, Morningside, Triventures, ION Crossover Partners.

Founded
2015
Headquarters
Bellevue, Washington, USA
Team size
51-200
Total funding
$40M

Value proposition

Extends continuity of care from clinic to home through AI-powered continuous monitoring, achieving 90% reduction in CHF readmissions and 80% improvement in hypertension control within 6 weeks

Products and solutions

AI-powered remote care management platform, Continuous patient monitoring system, Clinical decision support tools, Patient engagement and education platform, Remote nursing and coaching services

Unique value

Hybrid model blending AI-powered platform with human clinical expertise, creating 'always-on' continuous care that traditional healthcare models cannot offer. Achieves 204% patient growth with 82% retention and NPS of 66.

Target customer

Healthcare providers, health systems, and payers focused on managing patients with chronic conditions including CHF, hypertension, and diabetes

Industries served

Healthcare, Remote Patient Monitoring, Chronic Disease Management, Population Health Management

Technology advantage

AI assistant trained on 5+ million patient conversations over 5 years, combined with remote clinical teams for continuous monitoring. Implementation in 30 days with no additional clinician workload while creating new revenue streams.

How they differentiate

Combines AI platform with remote clinical teams for continuous care, focuses on health system partnerships rather than just device monitoring, achieves superior clinical outcomes (90% CHF readmission reduction vs competitors' 50%)

Main competitors

100Plus, Zero Longevity Science, Riva Health, Philips Healthcare, Medtronic, ResMed

Key partnerships

UMass Memorial Health (lead investor and customer), Morningside (co-lead investor), Multiple health systems nationwide

Notable customers

UMass Memorial Health, Multiple health systems nationwide

Major milestones

Raised $28M Series B funding (October 2025), Won top digital health award for AI-powered remote care management (December 2025), Achieved 90% reduction in CHF readmissions with partners, 204% patient growth over past year, National expansion of remote care platform, Won 2026 Pinnacle Award Platinum for AI in Healthcare & Life Sciences (March 2026), Published JMIR study on hypertension control outcomes (March 2026), Named Diamond Winner at 2026 Pinnacle Awards for Business Innovation

Growth metrics

204% patient growth YoY, 82% patient retention, NPS 66, 90% reduction in CHF readmissions, 80% increase in controlled hypertension populations within 6 weeks

Market positioning

Leader in AI-powered remote patient care management with proven clinical outcomes, positioned as comprehensive remote care solution rather than just RPM technology

Geographic focus

United States with national expansion following Series B funding

Patents and IP

No public patent information available

About Oren Nissim

Over two decades in digital health and mobile technology. Former Director and General Manager at Intel Corporation, co-founded Telmap (mobile mapping pioneer acquired by Intel), and co-founded Mustop in mobile content space.

Official website: